BIOPROGNOS

Non-invasive tests for early and accurate detection of cancer, based on a simple blood test.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Barcelona, Spain
  • Currency USD
  • Founded January 2016
  • Employees 6
  • Incorporation Type LLC
  • Website bioprognos.com

Company Summary

Biotechnological spin-off of Hospital Clínic de Barcelona that is focused in the development of solutions for the detection of different types of cancer from a simple blood test (that is, using non-invasive methods).

The flagship products are OncoBREAST Dx, OncoLUNG Dx, OncoOVARIAN Dx, OncoPROSTATE Dx and OncoCUP Dx, as well as the new Screening line (Sx) we are developing from all knowledge already acquired from Diagnosis (Dx) ones.

Team

  • Sergio is an all-terrain and born leader who, despite starting his professional career in the IT function, he moved to IT management first, and then to general management, acquiring knowledge from different sectors to have a 360 degree view of the different key business processes. He created Bioprognos after recovering from a Hodgkin lymphoma.

    Electronic Superior Technician, MSc in Telco (URL) and MSc in Business Administration (ESADE, URL).

  • Chief Marketing Officer

    Anna has developed most of her professional career in companies with an international focus, starting with the sales function to later jump to marketing and communication. This previous experience has been carried out to make changes in the market studies, as well as to communicate the subsequent consequence of the sale of the company's products or services.

    MSc in Marketing Management (ESADE, URL).

  • Chief Scientific Officer

    Lorena has a strong scientific and project management background, starting as a Researcher in Hospital Clínic de Barcelona carrying out Next Generation Sequencing methods for genetic disorders studies. Then she spent three years as a Researcher & Industrial Project Manager conducting and researching into innovative and pre-clinical services performed with in vitro cancerous cell lines models.

    Biochemistry and PgDip in Regulatory Affairs (UB).

  • Chief Sales Officer

Advisors

Previous Investors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free